Antisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849+10 kb C-to-T splicing mutation is a research paper published in Journal of Cystic Fibrosis (2021). On theSindex it has a DataRank of 1.6. It has been cited 53 times, with 44 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.598
From this paper's citation signal
Citation Network Contribution
0.973
From 35 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 44 citers.
Cystic Fibrosis Foundation
Grant: ROWE19R0
Cystic Fibrosis Foundation
Grant: KEREM13XX0
Cystic Fibrosis Foundation
Grant: KEREM15XX0
National Institutes of Health
Grant: P30DK072482
NHLBI NIH HHS
Grant: R01 HL139876
National Institutes of Health
Grant: 3P30DK072482-03S3
UAB CF Research and Translation Core Center
Government of Israel Ministry of Economy
FWCI
5.35
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals